Efficacy of Esomeprazole in Patients with Frequent Heartburn - NEXT1

Study identifier:D961RC00001

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Phase III Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of 14 Day Treatment with Esomeprazole 20 mg Once Daily in Subjects with Frequent Heartburn

Medical condition

Heartburn

Phase

Phase 3

Healthy volunteers

No

Study drug

Esomeprazole

Sex

All

Actual Enrollment

340

Study type

Interventional

Age

18 Years +

Date

Study Start Date: 01 Aug 2011
Primary Completion Date: 01 Oct 2011
Study Completion Date: 01 Oct 2011

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Feb 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria